Walter Olesiak

Walter Olesiak serves as a partner at Remiges Ventures, a US-based venture capital firm specializing in early-stage drug discovery and development. With extensive experience in the biopharmaceutical sector, Walter holds several significant roles including Board Observer positions at Glycomine Inc. and ENB Therapeutics, and a position on the Board of Directors at Omeicos Ophthalmics, Inc. Additionally, Walter acts as an i3 Advisor for the i3 Asset Accelerator at Mount Sinai Health System, fostering innovation in healthcare technology. Previous experience includes managing director roles and board positions at various pharmaceutical companies. Walter Olesiak holds an AB in Biochemical Sciences from Harvard University and an MBA from Cornell Johnson Graduate School of Management.